Search results
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 6 hours agoIf it ever had a reputation for trustworthiness, it doesn't have it any longer. Get the latest from...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 1 day agoThe advisory committee is set to meet on June 27. Merck set the price of Capvaxive at $287 per...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 13 hours agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Monday, Benzinga reports ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 2 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 1 day agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
Gateway - Quartz
Quartz· 1 day agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
New COVID Mystery? Those 'Excess Deaths'
newser· 3 days agoCOVID vaccines "were provided to guard civilians," but didn't always work as advertised. Clinical trials showed that Pfizer and Moderna vaccine ...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 7 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Studio Investment Management LLC Buys 2,236 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoStudio Investment Management LLC increased its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.1% during the 4th quarter, according to the company in its most ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
CNBC· 2 days agoThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and ...
